In the UK, quarterly HIV testing is recommended for high-risk men who have sex with men (MSM). In this manuscript we determined the risk of being newly diagnosed with HIV in MSM by their HIV testing history, considering both the frequency and periodicity of testing.
Introduction
In England, men who have sex with men (MSM) are at highest risk of HIV acquisition [1] The National Institute for Health and Care Excellence (NICE) recommends at least annual HIV screening in MSM, with more frequent testing in those at greater risk of exposure [2] Since 2012, MSM engaging in condomless sex with new or casual partners have been encouraged to be tested every 3 months [3] Quarterly testing recommendations have been extended to MSM disclosing drug use and in those with a newly diagnosed sexually transmitted infection (STI), both seen as proxies for high-risk sexual behaviour [4] .
Recent behavioural data suggest that annual testing guidelines are unlikely to be met and a little over a quarter of MSM engaging in condomless anal intercourse reported testing at least four times in a year [5] Despite modelling studies suggesting cost-effectiveness of quarterly testing for high-risk MSM [6, 7] there are limited UK observational studies that have evaluated testing frequency and HIV risk in high-risk MSM [8] Test periodicity (i.e. testing at regular intervals) was not incorporated in test frequency measurements used in previous analyses, despite recommendations for quarterly testing [9, 10] In addition, repeat testing and test recency were found to be associated with an increase in behavioural risk of HIV acquisition [11, 12] .
With these evidence gaps in mind, this analysis utilized longitudinal surveillance data to assess the probability of HIV diagnosis in MSM by HIV testing history, considering both the frequency and periodicity of testing.
Methods
Data were obtained from GUMCAD, the mandatory surveillance system for STIs in England. Details on GUM-CAD are provided elsewhere; [13] briefly, it is a patientlevel data set of all HIV/STI diagnoses and services at all sexual health clinics (SHCs) in England.
MSM were defined as men whose self-reported sexual orientation was gay or bisexual at least once throughout their clinic attendance history. All HIV-negative MSM at least 15 years of age who had at least one negative HIV antibody test in the 2 years preceding their first attendance in the period 1 January 2013 to 31 December 2014 were included in the analysis.
Time to HIV diagnosis was defined as the time from the date of the first attendance in 2013-2014 to the date when a new HIV diagnosis was reported. HIV testing pattern in the year preceding the first attendance in 2013-2014 was defined as follows: (1) no tests; (2) one test; (3) two tests, one in each 6-monthly period; (4) two tests in two consecutive quarters; (5) three tests, one in each of three distinct quarters of the year; (6) four tests, one in each quarter of the year ("quarterly testers"). Those who did not meet the above criteria were excluded from the analysis. This testing pattern was used to define testing behaviour and to distinguish between those who were tested regularly and those who were tested less frequently (Fig. S1 ).
Demographic confounders considered in the analysis include age group, self-reported ethnicity, world region of birth, residential area-level socioeconomic deprivation, and residence in London or elsewhere. In the absence of behavioural data in GUMCAD, the history of a bacterial STI (chlamydia, gonorrhoea, primary/secondary/tertiary syphilis, lymphogranuloma venereum, donovanosis or chancroid) within the year preceding the first attendance in 2013-2014 was used as an indicator of high-risk behaviour. A patient-level analysis was conducted with all confounders associated with the first attendance during 2013-2014. A KaplanÀMeier analysis was performed to investigate time to diagnosis by HIV testing pattern. Censorship was defined as the date of HIV diagnosis or as 31 December 2014 in those who were not diagnosed with HIV infection. Incidence rates (per 1000 person-years) and 95% confidence intervals (CIs) for HIV infection were determined. A Cox proportional hazards regression analysis was performed to determine the association between HIV testing pattern and time to diagnosis with and without adjustment for demographic confounders. Models were stratified by risk stratum, with 'high risk' defined as a history of a bacterial STI in the past year. Unadjusted and adjusted hazard ratios (HRs and aHRs, respectively) with 95% CIs are reported. All associations with a type I error rate< 5% were considered to be statistically significant. All analyses were performed using STATA v13.1 (StataCorp LP, College Station, TX).
Results
Of the 37 702 HIV-negative MSM who met the inclusion criteria and attended an SHC in 2013-2014, 217 (1%) were quarterly testers, 1183 (3%) had three tests, one in each of three distinct quarters of the year, 2414 (6%) had two tests in two consecutive quarters, 2343 (6%) had two tests, one in each 6-monthly period, 17 811 (47%) had one test and 13 734 (36%) did not have any tests in the year preceding their first attendance in 2013À2014. Overall, 1105 (3%) were diagnosed with HIV infection within the year following their first attendance in 2013-2014.
From the KaplanÀMeier analysis, the probability of being subsequently diagnosed with HIV infection within 1 year of the first attendance was highest in quarterly testers, with the lowest probability in those with one test in the past year (Fig. 1a) . HIV incidence rate per 1000 person-years was 52.0 (95% CI 28.8-93.9) for quarterly testers, compared with 20.3 (95% CI 17.9-23.0) and 17.5 (95% CI 15.7-19.6) for those with no tests and for those with one test in the past year, respectively.
When restricted to high-risk MSM (Fig. 1b) , the probability of being diagnosed with HIV within 1 year of the first attendance increased notably among quarterly testers. There was no difference in the probability of subsequent HIV diagnosis among low-risk MSM by testing pattern (Fig. 1c) .
Overall, the probability of being diagnosed with HIV infection within 12 months was significantly higher in quarterly testers (HR 2.66; 95% CI 1.46-4.87) and in those who had two tests in two consecutive quarters (HR 1.34; 95% CI 1.02-1.78), compared with those with no tests in the past year (Table 1a) . After adjusting for demographic characteristics, quarterly testers (aHR 2.51; 95% CI 1.33-4.74) and those who had two tests in two consecutive quarters (aHR 1.34; 95% CI 1.01-1.78) were significantly more likely to be subsequently diagnosed with HIV infection compared with those with no tests in the past year (Table 1a) .
Among high-risk MSM, quarterly testers were more likely to be subsequently diagnosed with HIV infection (HR 5.20; 95% CI 1.12-24.05) compared with those with no tests in the past year (Table 1b) . With adjustment for demographic factors, high-risk quarterly testers retained the highest probability of HIV diagnosis; however, this result marginally exceeded the type I error rate (aHR 4.48; 95% CI 0.97-21.17). Among low-risk MSM, the probability of HIV diagnosis in quarterly testers was not statistically different from that in those with no tests in the past year (Table 1b) .
Discussion
We found that MSM with a history of a bacterial STI and more frequent HIV testing were most likely to be diagnosed with HIV infection within 1 year of baseline, and this implies that frequent testers may have higher risk behaviours. Some of the differential in risk of HIV infection may be attributable to frequent testing being a proxy for high HIV infection risk and case ascertainment may be better in more frequent testers. Additionally, quarterly testing as a proxy for high HIV infection risk seems to be supported by the lack of any linear relationship between test frequency and HIV positivity. However, it is possible that more frequent testing in MSM with a history of a bacterial STI could increase the diagnosis rate of incident HIV infection.
The use of national surveillance data is a key strength of this study, as data are collected from all SHCs with 100% reporting compliance and > 90% completion for all variables collected [13] This provides a comprehensive overview of HIV testing and diagnoses nationally. Patients were categorized based on their HIV testing pattern in the year preceding the first attendance, and we assumed that HIV testing patterns prospectively (i.e. time from first attendance to new HIV diagnosis) were similar to those retrospectively. Under this assumption, no adjustment for testing pattern in the year following the first attendance in 2013-2014 was considered. Within GUMCAD, patient attendances can be linked within but not across SHCs; as a result, HIV testing frequency and diagnosis rates may have been underestimated. Venue loyalty is assumed given the history of testing within the same clinic. Small numbers within strata following adjustments for demographic factors limit the precision of measures of association. In addition, no behavioural data are collected through GUMCAD, so we were unable to assess the impact of behaviour on HIV testing pattern, but have defined risk based on the history of a bacterial STI [9] Testing is a key component of HIV prevention strategies to reduce the incidence of HIV infection and rates of late diagnosis of, and undiagnosed, HIV infection [14] Despite this, the evidence on testing frequency and HIV diagnosis in higher risk MSM is limited. A pattern of quarterly HIV testing may be more reflective of health-seeking behaviour in high-risk MSM [15, 16] but also presents more opportunities for earlier diagnosis and partner notification. Early identification of undiagnosed infection can improve individual outcomes and reduce onward transmission by facilitating quicker access to care, treatment initiation and behaviour change [17, 18] Our findings highlight that a history of a bacterial STI is a useful indicator of HIV risk in MSM and this should be acknowledged in HIV testing frequency guidelines. Quarterly HIV testing among MSM, especially those with history of a bacterial STI, is essential to ensure early diagnosis and to reduce the number of undiagnosed HIV infections. Increased HIV testing improves the likelihood of identifying undiagnosed HIV infection and quarterly testing should remain a continued recommendation for high-risk MSM. *High-risk based on the history of a bacterial sexually transmitted infection (chlamydia, gonorrhoea, primary/secondary/tertiary syphilis, lymphogranuloma venereum, donovanosis or chancroid) within the year preceding the first attendance in 2013-2014. † Analysis adjusted for age group, self-reported ethnicity, world region of birth, residential area-level deprivation and residence in London or elsewhere. HR, Hazard Ratio; CI, confidence interval. Adjusted and unadjusted hazard ratios calculated using Cox Proportional Hazards models. The hazard ratios reported in bold are considered to be statistically significant.
